4.4 Article Proceedings Paper

Design and Optimization of Soft Magnetic Composite Machines With Finite Element Methods

期刊

IEEE TRANSACTIONS ON MAGNETICS
卷 47, 期 10, 页码 4384-4390

出版社

IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
DOI: 10.1109/TMAG.2011.2157113

关键词

Electromagnetic devices; finite element (FE) methods; optimization; soft magnetic material

向作者/读者索取更多资源

In this paper, a synthesis of design methodologies for electromagnetic devices made with soft magnetic composite (SMC) material is presented. To realize efficient and low-cost SMC devices, it is necessary to benefit from interesting isotropic SMC material properties such as 3-D flux circulation path. In this case, the best approach is to carry out a topological structure research and perform a global optimization using physical models. However, the iterative optimization process can be computationally intensive and some compromises should be found between accuracy and computation time. One way is to use coarse models with important simplifying hypotheses but the optimal solution is often not valid. In this case, one can perform a limited number of finite element (FE) simulations to compute some correction coefficients and improve optimization convergence to a valid optimal solution. Another way is to perform the device optimization by using directly FE models with low mesh density and several simplifications of the device geometry. Such design approaches are illustrated by three concrete realizations with SMC material.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

Louis de Mestier, Thomas Walter, Camille Evrard, Paul de Boissieu, Olivia Hentic, Jerome Cros, David Tougeron, Catherine Lombard-Bohas, Vinciane Rebours, Pascal Hammel, Philippe Ruszniewski

NEUROENDOCRINOLOGY (2020)

Article Gastroenterology & Hepatology

The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma

Nicolas Pote, Jerome Cros, Samira Laouirem, Jerome Raffenne, Magda Negrao, Miguel Albuquerque, Pierre Bedossa, Miguel Godinho Ferreira, Slimane Ait Si Ali, Rita Fior, Valerie Paradis

LIVER INTERNATIONAL (2020)

Article Endocrinology & Metabolism

The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine Tumors

Louis de Mestier, Anne-Laure Vedie, Matthieu Faron, Jerome Cros, Vinciane Rebours, Olivia Hentic, Christine Do Cao, Pascal Bardet, Philippe Levy, Alain Sauvanet, Philippe Ruszniewski, Pascal Hammel

NEUROENDOCRINOLOGY (2020)

Article Endocrinology & Metabolism

Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology

Jerome Cros, Nathalie Theou-Anton, Valerie Gounant, Remy Nicolle, Cecile Reyes, Sarah Humez, Segolene Hescot, Vincent Thomas de Montpreville, Serge Guyetant, Jean-Yves Scoazec, Alice Guyard, Louis de Mestier, Solenn Brosseau, Pierre Mordant, Yves Castier, David Gentien, Philippe Ruszniewski, Gerard Zalcman, Anne Couvelard, Aurelie Cazes

NEUROENDOCRINOLOGY (2020)

Article Pathology

Clinicopathologic features and postoperative outcome of the radiation-induced enteritis: a retrospective study of 41 patients

Jerome Didier, Francisca Joly, Jerome Cros, Nathalie Guedj, Yves Panis, Dominique Cazals-Hatem

ANNALES DE PATHOLOGIE (2020)

Article Gastroenterology & Hepatology

22G Acquire vs. 20G Procore needle for endoscopic ultrasound-guided biopsy of pancreatic masses: a randomized study comparing histologic sample quantity and diagnostic accuracy

David Karsenti, Laurent Palazzo, Bastien Perrot, Jacqueline Zago, Anne-Isabelle Lemaistre, Jerome Cros, Bertrand Napoleon

ENDOSCOPY (2020)

Article Endocrinology & Metabolism

Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference?

Elettra Merola, Wouter Zandee, Louis de Mestier, Heinz Josef Klumpen, Karolina Makulik, Karen Geboes, Marie Louise van Velthuysen, Anne Couvelard, Jerome Cros, Susanne van Eeden, Anne Hoorens, Timothy Stephenson, W. Zajgckil, Wouter de Herder, Alia Munir

NEUROENDOCRINOLOGY (2020)

Letter Gastroenterology & Hepatology

Could pancreatic grade 3 neuroendocrine tumors really behave similarly to neuroendocrine carcinomas following resection?

Louis de Mestier, Caroline Lacombe, Anne Couvelard, Philippe Ruszniewski, Jerome Cros

Article Gastroenterology & Hepatology

Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages

Remi Samain, Alexia Brunel, Thibault Douche, Marjorie Fanjul, Stephanie Cassant-Sourdy, Julia Rochotte, Jerome Cros, Cindy Neuzillet, Jerome Raffenne, Camille Duluc, Aurelie Perraud, Jeremy Nigri, Veronique Gigoux, Ivan Bieche, Matteo Ponzo, Gilles Carpentier, Ilaria Cascone, Richard Tomasini, Herbert A. Schmid, Muriel Mathonnet, Remy Nicolle, Marie-Pierre Bousquet, Yvan Martineau, Stephane Pyronnet, Christine Jean, Corinne Bousquet

Summary: The study suggests that SOM230 has the potential to be an effective anti-metastatic therapy in PDA by regulating stromal activities, reducing inflammatory responses, and improving the immunosuppressive tumor microenvironment. This pharmacotherapy shows promise in reshaping the tumor environment and enhancing treatment outcomes for pancreatic cancer patients.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Oncology

A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma

R. Nicolle, O. Gayet, P. Duconseil, C. Vanbrugghe, J. Roques, M. Bigonnet, Y. Blum, N. Elarouci, L. Armenoult, M. Ayadi, A. de Reynies, F. Puleo, J. Augustin, J. F. Emile, M. Svrcek, T. Arsenijevic, P. Hammel, M. Giovannini, P. Grandval, L. Dahan, V Moutardier, M. Gilabert, J. L. Van Laethem, J. B. Bachet, J. Cros, J. Iovanna, N. J. Dusetti

Summary: The study demonstrates that the RNA-based GemPred stratification can predict the benefit of adjuvant gemcitabine in PDAC patients.

ANNALS OF ONCOLOGY (2021)

Letter Gastroenterology & Hepatology

Familial Pancreatic Intraductal Papillary and Mucinous Neoplasms Do Not Carry Constitutional or Postzygotic GNAS Activating Mutations

Sebastien Gaujoux, Alina Parvanescu, Grazia Fusco, Agnes Linglart, Alain Sauvanet, Anne Couvelard, Philippe Levy, Vinciane Rebours, Jerome Cros

PANCREAS (2021)

Article Oncology

Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features

Jerome Raffenne, Fernando A. Martin, Remy Nicolle, Marina Konta, Yuna Blum, Jerome Torrisani, Francesco Puleo, Jean Baptiste Bachet, Magali Svrcek, Armel Bardier-Dupas, Jean Francois Emile, Peter Demetter, Miroslav Radman, Jean Luc Van Laethem, Pascal Hammel, Vinciane Rebours, Valerie Paradis, Anne Couvelard, Jerome Cros

Summary: Pancreatic ductal adenocarcinoma (PDAC) is typically diagnosed in the 7th decade, but around 10% of patients are diagnosed before the age of 55. Molecular features of early-onset tumors (<= 55 y.o.) were found to be similar to late-onset tumors (>= 70 y.o.), indicating that younger patients can serve as a good molecular surrogate model for the general older population with PDAC. The study also highlighted the impact of ageing on DNA methylation and proteome integrity, as well as the association of oxidative stress responses with PDAC.

CANCERS (2021)

Article Oncology

Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms

Caroline Lacombe, Ophelie De Rycke, Anne Couvelard, Anthony Turpin, Aurelie Cazes, Olivia Hentic, Valerie Gounant, Gerard Zalcman, Philippe Ruszniewski, Jerome Cros, Louis de Mestier

Summary: Grade 3 neuroendocrine neoplasms (G3 NEN) are a heterogeneous subtype of NEN, including well-differentiated tumors (NET) and poorly differentiated large (LCNEC) or small (SCNEC) cell carcinomas. Response to etoposide-platinum (EP) chemotherapy varies among these subtypes, with Rb < 150 identified as the best predictive biomarker for response to EP treatment.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights

Leo Mas, Renato M. Lupinacci, Jerome Cros, Jean-Baptiste Bachet, Florence Coulet, Magali Svrcek

Summary: IPMCs are a main precursor lesion of PDAC, with distinct subtypes and specific clinical-pathological features and genomic hallmarks. Intestinal IPMNs and associated colloid carcinomas are linked to less aggressive features.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

AGAP3: A novel BRAF fusion partner in pediatric pancreatic-type acinar cell carcinoma

Charlotte Paoli, Fanny Burel-Vandenbos, Aurore Coulom-l'Hermine, Jerome Cros, Morgane Pondrom, Valerie Kubiniek, Florence Pedeutour, Berengere Dadone-Montaudie

Summary: Most molecular data on PACC come from studies of adult cases, with limited data available on pediatric cases. This study reports the comprehensive analysis of a 6-year-old patient with PACC, revealing an AGAP3::BRAF fusion gene. The presence of a BRAF rearrangement in both adult and pediatric cases suggests a molecular link between them.

GENES CHROMOSOMES & CANCER (2022)

暂无数据